Latest News & Features
Pharma
Belgium head-quartered pharmaceutical company UCB is to acquire Ra Pharmaceuticals for approximately $2.1 billion. 14 October 2019
Pharma
Actavis Laboratories cannot market a generic version of Horizon Pharma’s knee pain treatment, an appeals court has ruled. 11 October 2019
Asia
Hong Kong-based Insilico Medicine has agreed an artificial intelligence breast cancer drug discovery partnership worth a potential $200 million with a Chinese pharmaceutical company. 10 October 2019
Pharma
Johnson & Johnson has committed $500 million to research and development programmes over the next four years in a bid to eliminate HIV and tuberculosis across the world by 2030. 10 October 2019
Pharma
African drugmaker Aspen was able to increase its prices for fludrocortisone acetate tablets by 1,800% in the UK, as a result of collusion with two other firms, according to the UK’s Competition and Markets Authority. 9 October 2019
Americas
California has become the first US state to ban pay-for-delay deals in the pharmaceutical industry. 9 October 2019
Pharma
The English High Court has sided with pharmaceutical company Vectura and Novartis-owned Sandoz in a passing off lawsuit brought by rival GSK. 8 October 2019
Americas
The US Court of Appeals for the Federal Circuit last week reversed a Patent Trial and Appeal Board decision, which found that claims in an OSI Pharmaceuticals patent for cancer treatment were obvious. 7 October 2019
Pharma
A US subsidiary of Chinese genome sequencing company BGI has filed a patent infringement counterclaim against Illumina. 4 October 2019
Americas
LSX World Congress USA brings life sciences investment and partnering to Boston. 4 October 2019